that synchrotron data are ideal for structure solution ‎‎[1]. ‎



In this study, we focused on structure determination of 6-(4-(4-methylpiperazin-1-yl)-4-oxobutoxy)-4-‎methylquinolin-2(1H)-one as a phosphodiesterase (PDE) enzymes inhibitor which...

-(4-(4-

methylpiperazin-1-yl)-4-oxobutoxy)-4-methylquinolin-2(1H)-one as a phosphodiesterase (PDE)

enzymes inhibitor which improve cardiac contractility and may be used in congestive heart failure

(CHF) which is a major cause of death...